The anesthetic management for a patient with trisomy 13

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Trisomy 13 is a chromosomal disorder that occurs in complete or partial mosaic forms. It is characterized by central apnea, mental retardation, seizure and congenital heart disease. The survival of the patients with trisomy 13 is the majority dying before one month. Trisomy 13 is the worst life prognosis among all trisomy syndromes. It is reported the cause of death is central apnea. Special needs patients with mental retardation are recognized to have poorer oral health condition. Oral health related quality of life reflects daily activity and well-being. Dental treatment under general anesthesia is sometimes an option for such patients. This patient had received ventricular septal defect closure surgery at 2-year-old. In addition, he had mental retardation and seizure. Dental treatment had been completed without any cerebral and cardiovascular events under non-invasive monitoring with not only cardiac electric velocimetry, but also epileptogenic activity. In addition, postoperative respiratory condition was maintained stable in room air.

Original languageEnglish
Pages (from-to)162-164
Number of pages3
JournalAnesthesia progress
Volume64
Issue number3
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Anesthetics
Intellectual Disability
Central Sleep Apnea
Oral Health
Tooth
Seizures
Chromosome Disorders
Rheology
Ventricular Heart Septal Defects
Trisomy
General Anesthesia
Cause of Death
Heart Diseases
Air
Quality of Life
Survival
Trisomy 13 syndrome
Therapeutics

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

The anesthetic management for a patient with trisomy 13. / Tsukamoto, Masanori; Hitosugi, Takashi; Esaki, Kanako; Yokoyama, Takeshi.

In: Anesthesia progress, Vol. 64, No. 3, 01.09.2017, p. 162-164.

Research output: Contribution to journalArticle

@article{6921c94aea7645c5957f1b2224271ea9,
title = "The anesthetic management for a patient with trisomy 13",
abstract = "Trisomy 13 is a chromosomal disorder that occurs in complete or partial mosaic forms. It is characterized by central apnea, mental retardation, seizure and congenital heart disease. The survival of the patients with trisomy 13 is the majority dying before one month. Trisomy 13 is the worst life prognosis among all trisomy syndromes. It is reported the cause of death is central apnea. Special needs patients with mental retardation are recognized to have poorer oral health condition. Oral health related quality of life reflects daily activity and well-being. Dental treatment under general anesthesia is sometimes an option for such patients. This patient had received ventricular septal defect closure surgery at 2-year-old. In addition, he had mental retardation and seizure. Dental treatment had been completed without any cerebral and cardiovascular events under non-invasive monitoring with not only cardiac electric velocimetry, but also epileptogenic activity. In addition, postoperative respiratory condition was maintained stable in room air.",
author = "Masanori Tsukamoto and Takashi Hitosugi and Kanako Esaki and Takeshi Yokoyama",
year = "2017",
month = "9",
day = "1",
doi = "10.2344/anpr-64-02-09",
language = "English",
volume = "64",
pages = "162--164",
journal = "Anesthesia Progress",
issn = "0003-3006",
publisher = "Allen Press Inc.",
number = "3",

}

TY - JOUR

T1 - The anesthetic management for a patient with trisomy 13

AU - Tsukamoto, Masanori

AU - Hitosugi, Takashi

AU - Esaki, Kanako

AU - Yokoyama, Takeshi

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Trisomy 13 is a chromosomal disorder that occurs in complete or partial mosaic forms. It is characterized by central apnea, mental retardation, seizure and congenital heart disease. The survival of the patients with trisomy 13 is the majority dying before one month. Trisomy 13 is the worst life prognosis among all trisomy syndromes. It is reported the cause of death is central apnea. Special needs patients with mental retardation are recognized to have poorer oral health condition. Oral health related quality of life reflects daily activity and well-being. Dental treatment under general anesthesia is sometimes an option for such patients. This patient had received ventricular septal defect closure surgery at 2-year-old. In addition, he had mental retardation and seizure. Dental treatment had been completed without any cerebral and cardiovascular events under non-invasive monitoring with not only cardiac electric velocimetry, but also epileptogenic activity. In addition, postoperative respiratory condition was maintained stable in room air.

AB - Trisomy 13 is a chromosomal disorder that occurs in complete or partial mosaic forms. It is characterized by central apnea, mental retardation, seizure and congenital heart disease. The survival of the patients with trisomy 13 is the majority dying before one month. Trisomy 13 is the worst life prognosis among all trisomy syndromes. It is reported the cause of death is central apnea. Special needs patients with mental retardation are recognized to have poorer oral health condition. Oral health related quality of life reflects daily activity and well-being. Dental treatment under general anesthesia is sometimes an option for such patients. This patient had received ventricular septal defect closure surgery at 2-year-old. In addition, he had mental retardation and seizure. Dental treatment had been completed without any cerebral and cardiovascular events under non-invasive monitoring with not only cardiac electric velocimetry, but also epileptogenic activity. In addition, postoperative respiratory condition was maintained stable in room air.

UR - http://www.scopus.com/inward/record.url?scp=85028752201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028752201&partnerID=8YFLogxK

U2 - 10.2344/anpr-64-02-09

DO - 10.2344/anpr-64-02-09

M3 - Article

C2 - 28858551

AN - SCOPUS:85028752201

VL - 64

SP - 162

EP - 164

JO - Anesthesia Progress

JF - Anesthesia Progress

SN - 0003-3006

IS - 3

ER -